ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.4927
Delayed Data
As of 4:00pm ET
 +0.0217 / +4.61%
Today’s Change
0.43
Today|||52-Week Range
1.45
-32.51%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.47
Today’s open0.51
Day’s range0.47 - 0.51
Volume408,906
Average volume (3 months)835,435
Market cap$42.5M
Dividend yield--
Data as of 4:00pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
OPGNOpGen Inc-0.12-3.29%
--Protea Biosciences G...0.000.00%
ABACAoxin Tianli Group I...+0.02+1.27%
AEZSAEterna Zentaris Inc-0.02-6.78%
Data as of 4:00pm ET, 05/27/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers